Egg Consumption and Mortality Due to Cardiovascular Events

According to this study recently published in prestigious journal JAMA, eating too much cholesterol or eggs (which have a high concentration of it in the yolk) is significantly associated with a higher risk of cardiovascular events and all-cause mortality, with a typical dose/effect curve. According to the authors, this information should be considered for an update of current dietary guidelines.

colesterol ldl placas coronarias

Cholesterol is a common nutrient in any non-vegan diet and eggs are its main source. Recommendations on egg consumption have seen many different stages: from regarding it as “public enemy #1” to encouraging its consumption. This work seeks to put an end to controversy and deliver definitive information.

This analysis included 29,615 participants with a mean age of about 50 years old and a mean follow-up of 17.5 years.

For each additional 300 mg of dietary cholesterol consumed per day (very hard to measure in daily practice) or each additional half an egg per day (much easier to measure), there was a significant increase in cardiovascular events (adjusted hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.09 to 1.26) and all-cause mortality (adjusted HR: 1.18; 95% CI: 1.10 to 1.26).


Read also: Strict LDL Monitoring Helps Reduce Plaque Volume.


The association between egg consumption and cardiovascular events or all-cause death was no longer significant after adjusting for dietary cholesterol consumption. This might mean that the problem lies in cholesterol itself, and that eggs are simply an easy way to measure it. There might not be any additional deleterious component (other than cholesterol) in eggs. Reducing egg consumption ultimately reduces cholesterol consumption.

Original Title: Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Reference: Victor W. Zhong et al. JAMA. 2019;321(11):1081-1095.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

New Balloon-Expandable Aortic Valve: 30-Day Outcomes in Patients with Small Aortic Annulus

As transcatheter aortic valve implantation (TAVI) continues to expand toward younger patients with longer life expectancy, factors such as valve hemodynamic performance, durability, and...